Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Insurance coverage for brand-name tirzepatide Insurance coverage for tirzepatide depends almost entirely on the specific indication
We also operate charitable programs such as patient starter kits, access navigation tools, and prescription assistance resources all designed to make GLP-1 care more affordable, approachable, and equitable
If youre stopping because of cost concerns: GLP-1 medications are often a long-term commitment, not a quick fix
Overview of main clinical studies for MASLD/MASH with GLP-1 receptor agonists and dual or triple agonists targeting glucagon/GIP/GLP-1 receptors Liraglutide Liraglutide, a once-daily GLP-1 receptor agonist with authorized indications for type 2 diabetes and obesity, was evaluated in the LEAN trial (NCT01237119), a phase 2 randomized controlled study enrolling 52 adults with biopsy-proven MASH [22]
Many providers consider it the next evolution of GLP-1 therapy
